{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T02:31:57Z","timestamp":1791945117795,"version":"4.3.4"},"reference-count":33,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2012,8,1]],"date-time":"2012-08-01T00:00:00Z","timestamp":1343779200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["European Journal of Pharmaceutical Sciences"],"published-print":{"date-parts":[[2012,8]]},"DOI":"10.1016\/j.ejps.2012.05.006","type":"journal-article","created":{"date-parts":[[2012,5,30]],"date-time":"2012-05-30T10:47:52Z","timestamp":1338374872000},"page":"117-123","source":"Crossref","is-referenced-by-count":11,"title":["LDL S-homocysteinylation decrease in chronic kidney disease patients undergone lipid lowering therapy"],"prefix":"10.1016","volume":"47","author":[{"given":"Angelo","family":"Zinellu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Salvatore","family":"Sotgia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisabetta","family":"Pisanu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giacomina","family":"Loriga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luca","family":"Deiana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea Ercole","family":"Satta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ciriaco","family":"Carru","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejps.2012.05.006_b0005","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1016\/S0140-6736(05)67394-1","article-title":"Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90,056 participants in 14 randomised trials of statins","volume":"366","author":"Baigent","year":"2005","journal-title":"Lancet"},{"key":"10.1016\/j.ejps.2012.05.006_b0010","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1016\/j.sbi.2004.09.012","article-title":"The role of cysteine residues as redox-sensitive regulatory switches","volume":"14","author":"Barford","year":"2004","journal-title":"Curr. Opin. Struct. Biol."},{"key":"10.1016\/j.ejps.2012.05.006_b0015","doi-asserted-by":"crossref","first-page":"S4","DOI":"10.1038\/ki.2008.516","article-title":"Oxidative stress and inflammation, a link between chronic kidney disease and cardiovascular disease","volume":"74","author":"Cachofeiro","year":"2008","journal-title":"Kidney Int. Suppl."},{"key":"10.1016\/j.ejps.2012.05.006_b0020","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1002\/elps.200305768","article-title":"Plasma thiols redox status by laser-induced fluorescence capillary electrophoresis","volume":"25","author":"Carru","year":"2004","journal-title":"Electrophoresis"},{"key":"10.1016\/j.ejps.2012.05.006_b0025","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1111\/j.1463-1326.2009.01152.x","article-title":"Ezetimibe added to atorvastatin compared with doubling the atorvastatin dose in patients at high risk for coronary heart disease with diabetes mellitus, metabolic syndrome or neither","volume":"12","author":"Conard","year":"2010","journal-title":"Diabetes Obes. Metab."},{"key":"10.1016\/j.ejps.2012.05.006_b0030","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1517\/14740338.3.2.101","article-title":"The effect of fibrates and other lipid-lowering drugs on plasma homocysteine levels","volume":"3","author":"Dierkes","year":"2004","journal-title":"Expert. Opin. Drug. Saf."},{"key":"10.1016\/j.ejps.2012.05.006_b0035","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1053\/j.ajkd.2006.08.015","article-title":"Oxidative stress is progressively enhanced with advancing stages of CKD","volume":"48","author":"Dounousi","year":"2006","journal-title":"Am. J. Kidney Dis."},{"key":"10.1016\/j.ejps.2012.05.006_b0040","doi-asserted-by":"crossref","first-page":"8132","DOI":"10.1073\/pnas.0500269102","article-title":"The target of ezetimibe is Niemann\u2013Pick c1-like 1 (npc1l1)","volume":"102","author":"Garcia-Calvo","year":"2005","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ejps.2012.05.006_b0045","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1056\/NEJMoa041031","article-title":"Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization","volume":"351","author":"Go","year":"2004","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ejps.2012.05.006_b0050","doi-asserted-by":"crossref","first-page":"9987","DOI":"10.1074\/jbc.273.16.9987","article-title":"Tissue plasminogen activator binding to the annexin II tail domain. Direct modulation by homocysteine","volume":"273","author":"Hajjar","year":"1998","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ejps.2012.05.006_b0055","doi-asserted-by":"crossref","unstructured":"Heart Protection Study Collaborative Group. MRC\/BHF Heart Protection, 2002 Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomized placebo-controlled trial. Lancet 360, 7-22.","DOI":"10.1016\/S0140-6736(02)09327-3"},{"key":"10.1016\/j.ejps.2012.05.006_b0060","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/S0009-8981(97)00197-6","article-title":"Protein binding of homocysteine and other thiols in HeLa cell cultures after addition of homocysteine and copper ions","volume":"269","author":"Hultberg","year":"1998","journal-title":"Clin. Chim. Acta"},{"key":"10.1016\/j.ejps.2012.05.006_b0065","first-page":"2","article-title":"Synergistic effect of simvastatin and ezetimibe on lipid and pro-inflammatory profiles in pre-diabetic subjects","volume":"7","author":"Kater","year":"2010","journal-title":"Diabetol. Metab. Syndr."},{"key":"10.1016\/j.ejps.2012.05.006_b0070","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1177\/1074248408318628","article-title":"An overview of the extra-lipid effects of rosuvastatin","volume":"13","author":"Kostapanos","year":"2008","journal-title":"J. Cardiovasc. Pharmacol. Ther."},{"key":"10.1016\/j.ejps.2012.05.006_b0075","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1007\/s11745-011-3539-z","article-title":"Ezetimibe treatment lowers indicators of oxidative stress in hypercholesterolemic subjects with high oxidative stress","volume":"46","author":"Kostapanos","year":"2011","journal-title":"Lipids"},{"key":"10.1016\/j.ejps.2012.05.006_b0080","doi-asserted-by":"crossref","first-page":"1354","DOI":"10.1161\/01.ATV.0000023899.93940.7C","article-title":"Homocysteine binds to human plasma fibronectin and inhibits its interaction with fibrin","volume":"22","author":"Majors","year":"2002","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.ejps.2012.05.006_b0085","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1177\/0091270003255920","article-title":"Comparative effects of atorvastatin, simvastatin, and fenofibrate on serum homocysteine levels in patients with primary hyperlipidemia","volume":"43","author":"Milionis","year":"2003","journal-title":"J. Clin. Pharmacol."},{"key":"10.1016\/j.ejps.2012.05.006_b0090","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1093\/qjmed\/hci093","article-title":"The statin studies: from targeting hypercholesterolaemia to targeting the high-risk patient","volume":"98","author":"Ong","year":"2005","journal-title":"QJM"},{"key":"10.1016\/j.ejps.2012.05.006_b0095","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1177\/1753944707082714","article-title":"HMG CoA reductase inhibitors and renoprotection: the weight of the evidence","volume":"1","author":"Romayne Kurukulasuriya","year":"2007","journal-title":"Ther Adv Cardiovasc Dis"},{"key":"10.1016\/j.ejps.2012.05.006_b0100","doi-asserted-by":"crossref","first-page":"2154","DOI":"10.1161\/01.CIR.0000095676.90936.80","volume":"108","author":"Sarnak","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.ejps.2012.05.006_b0105","doi-asserted-by":"crossref","first-page":"30111","DOI":"10.1074\/jbc.M104324200","article-title":"Albumin thiolate anion is an intermediate in the formation of albumin-S\u2013S-homocysteine","volume":"276","author":"Sengupta","year":"2001","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ejps.2012.05.006_b0110","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1016\/S0140-6736(03)12948-0","volume":"361","author":"Sever","year":"2003","journal-title":"Lancet"},{"key":"10.1016\/j.ejps.2012.05.006_b0115","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1016\/j.amjcard.2007.09.099","article-title":"Efficacy and tolerability of fluvastatin XL 80mg alone, ezetimibe alone, and the combination of fluvastatin XL 80mg with ezetimibe in patients with a history of muscle-related side effects with other statins","volume":"101","author":"Stein","year":"2008","journal-title":"Am. J. Cardiol."},{"key":"10.1016\/j.ejps.2012.05.006_b0120","doi-asserted-by":"crossref","first-page":"4389","DOI":"10.1074\/jbc.M004124200","article-title":"Homocysteine inhibits inactivation of factor Va by activated protein C","volume":"276","author":"Undas","year":"2001","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ejps.2012.05.006_b0125","doi-asserted-by":"crossref","first-page":"F262","DOI":"10.1152\/ajprenal.00099.2005","article-title":"Dyslipidemia of chronic renal failure: the nature, mechanisms, and potential consequences","volume":"290","author":"Vaziri","year":"2006","journal-title":"Am. J. Physiol. Renal Physiol."},{"key":"10.1016\/j.ejps.2012.05.006_b0130","doi-asserted-by":"crossref","first-page":"2524","DOI":"10.4049\/jimmunol.161.5.2524","article-title":"Advanced oxidation protein products as novel mediators of inflammation and monocyte activation in chronic renal failure","volume":"161","author":"Witko-Sarsat","year":"1998","journal-title":"J. Immunol."},{"key":"10.1016\/j.ejps.2012.05.006_b0135","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1053\/j.ajkd.2005.09.029","article-title":"The determinants of endothelial dysfunction in CKD: oxidative stress and asymmetric dimethylarginine","volume":"47","author":"Yilmaz","year":"2006","journal-title":"Am. J. Kidney Dis."},{"key":"10.1016\/j.ejps.2012.05.006_b0140","doi-asserted-by":"crossref","first-page":"2796","DOI":"10.1002\/elps.200305570","article-title":"N-methyl-D-glucamine improves the laser-induced fluorescence capillary electrophoresis performance in the total plasma thiols measurement","volume":"24","author":"Zinellu","year":"2003","journal-title":"Electrophoresis"},{"key":"10.1016\/j.ejps.2012.05.006_b0145","doi-asserted-by":"crossref","first-page":"2575","DOI":"10.1002\/elps.200500762","article-title":"Distribution of low-density lipoproteinbound low-molecular-weight thiols: a new analytical approach","volume":"27","author":"Zinellu","year":"2006","journal-title":"Electrophoresis"},{"key":"10.1016\/j.ejps.2012.05.006_b0150","doi-asserted-by":"crossref","first-page":"2054","DOI":"10.1373\/clinchem.2006.071142","article-title":"Factors affecting S-homocysteinylation of LDL apoprotein B","volume":"52","author":"Zinellu","year":"2006","journal-title":"Clin. Chem."},{"key":"10.1016\/j.ejps.2012.05.006_b0155","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.atherosclerosis.2009.01.035","article-title":"S-homocysteinylated LDL apolipoprotein B adversely affects human endothelial cells in vitro","volume":"206","author":"Zinellu","year":"2009","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.ejps.2012.05.006_b0160","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1159\/000319012","article-title":"Increased low-density lipoprotein S-homocysteinylation in chronic kidney disease","volume":"32","author":"Zinellu","year":"2010","journal-title":"Am. J. Nephrol."},{"key":"10.1016\/j.ejps.2012.05.006_b0165","doi-asserted-by":"crossref","first-page":"2855","DOI":"10.1007\/s00216-010-4648-x","article-title":"Field-amplified sample injection combined with pressure-assisted capillary electrophoresis UV detection for the simultaneous analysis of allantoin, uric acid, and malondialdehyde in human plasma","volume":"399","author":"Zinellu","year":"2011","journal-title":"Anal. Bioanal. Chem."}],"container-title":["European Journal of Pharmaceutical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0928098712002333?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0928098712002333?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,6,23]],"date-time":"2023-06-23T00:42:55Z","timestamp":1687480975000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0928098712002333"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,8]]},"references-count":33,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2012,8]]}},"alternative-id":["S0928098712002333"],"URL":"https:\/\/doi.org\/10.1016\/j.ejps.2012.05.006","relation":{},"ISSN":["0928-0987"],"issn-type":[{"value":"0928-0987","type":"print"}],"subject":[],"published":{"date-parts":[[2012,8]]}}}